August 5, 2025Bleeding Thrombosis and Vascular BiologyOpen Access

CO32 | Major surgery in patients with severe hemophilia A without inhibitors receiving prophylaxis with fitusiran

View Full Paper

Ask AI

Bookmark

Discussion

Member takes

Implication

Clinical observations indicate successful hemostatic control during major surgeries in hemophilia A patients receiving fitusiran prophylaxis, suggesting safety of this procedure.

Key Points

Major surgeries in patients with severe hemophilia A receiving fitusiran were completed without complications.
All procedures achieved excellent hemostatic control with minimal blood loss and no transfusions needed.
Fitusiran was administered without interruption, indicating successful perioperative management strategies.
The absence of bleeding, significant anemia, and thrombotic events highlights the safety of using fitusiran.

Cite This Study

A 2025 study studied this question.

synapsesocial.com/papers/689521f09f4f1c896c4286ef https://doi.org/10.4081/btvb.2025.239

View Full Paper

Ask AI

Bookmark

Implication

Clinical observations indicate successful hemostatic control during major surgeries in hemophilia A patients receiving fitusiran prophylaxis, suggesting safety of this procedure.

CO32 | Major surgery in patients with severe hemophilia A without inhibitors receiving prophylaxis with fitusiran

Discussion

Member takes

Implication

Key Points

Cite This Study

CO32 | Major surgery in patients with severe hemophilia A without inhibitors receiving prophylaxis with fitusiran

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider